Justin Moser

Justin Moser, MD

Hematology Oncology
Languages: English
HonorHealth Medical Group

Insurance accepted

Please select a health insurance provider to view HonorHealth accepted plans.

Insurance Plans

  • AHCCCS Complete Care.
  • AHCCCS CRS
  • Dual-SNP
  • 3 Tier Plans
  • Banner Employees - Tier 2
  • HMO
  • PPO
  • EPO
  • Ameriben
  • POS
  • Indemnity
  • CHS
  • Alliance Network
  • FEP (Standard, Basic and Blue Focus),
  • Workers' Comp
  • EverydayHealth PPO,
  • BluePathway Plan 2 - Medicare Advantage
  • BluePathway Plan 3 - - Medicare Advantage
  • BlueJourney PPO - Medicare Advantage
  • Classic/Plus - Medicare Advantage
  • Medisun - Medicare Advantage
  • All
  • HMO
  • PPO
  • PPO Plus
  • POS
  • EPO
  • LocalPlus
  • Open Access Plan (OAP)
  • CignaChoice Fund Access Plus
  • Open Access Plus
  • PPO
  • RAN
  • PPO

HonorHealth accepts most health insurance plans at its hospitals and physician offices. However, you need to contact your health insurance company to verify your coverage for individual physicians/providers and their physicians before you seek services.

Specialties

  • Hematology Oncology

Credentials

  • Residency

    Mayo Clinic
  • Education

    University of Iowa Roy J. and Lucille A. Carver College of Medicine
  • Fellowship

    University of Utah School of Medicine
  • Board Certifications

    American Board of Internal Medicine - Medical Oncology, American Board of Internal Medicine - Hematology, American Board of Internal Medicine - Internal Medicine

About

HonorHealth Cancer Care gives you access to an elite team of experts across the Valley. The physicians we collaborate with are nationally and internationally recognized.

Dr. Moser is a medical oncologist who specializes in the development of new cancer therapies to treat Melanoma, Squamous cell carcinoma of the Skin, Merkel cell carcinoma, Basal cell carcinoma and Uveal melanoma. Dr. Moser is one of the few physicians in Arizona to offer intratumoral injections for the treatment of Melanoma. He is involved in clinical trials testing new anti-cancer therapies for patients with all types of cancer, but a particular focus for patients with skin cancers.

Dr. Moser has a special focus on Uveal melanoma (eye cancer), and has an active translational research program focused on better understanding this rare tumor. He is actively developing new clinical trials and treatment options for patients with this disease.